1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
9.68M
No peer data available for comparison.
-1.93M
No peer data available for comparison.
-1.38
No peer data available for comparison.
-41.62M
No peer data available for comparison.
-1.93M
No peer data available for comparison.
358.54M
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-21.77M
Worse than EXEL's ebitda of 110.06M.
100.00%
Better than EXEL's ebitda margin of 11.14%.
-22.21M
Worse than EXEL's ebit of 96.09M.
100.00%
Better than EXEL's ebit margin of 9.73%.
447.00K
Better than EXEL's depreciation of 13.97M.
63.56M
Worse than EXEL's total cash of 1.21B.
100.00%
Worse than EXEL's cash as percentage of revenue of 122.18%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than EXEL's receivables as percentage of revenue of 16.29%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Worse than EXEL's inventories as percentage of revenue of 2.12%.
4.34M
Better than EXEL's accounts payable of 23.63M.
100.00%
Worse than EXEL's payables as percentage of revenue of 2.39%.
-253.00K
Worse than EXEL's capital expenditure of -30.34M.
100.00%
Worse than EXEL's capex as percentage of revenue of -3.07%.
4.99%
Better than EXEL's weighted average cost of capital (wacc) of 6.62%.
5.02%
Better than EXEL's cost of equity of 6.67%.
4.08%
Better than EXEL's cost of debt of 4.26%.
-0.23
Better than EXEL's beta of 0.51.
30.07M
Better than EXEL's diluted shares outstanding of 321.46M.
1.57M
Better than EXEL's total debt of 189.94M.
49.31M
Worse than EXEL's total equity of 11.10B.
50.89M
Worse than EXEL's total capital of 11.29B.
3.09%
Worse than EXEL's debt weighting of 1.68%.
96.91%
Worse than EXEL's equity weighting of 98.32%.
-22.04M
Worse than EXEL's ebiat of 82.09M.
-17.50M
Worse than EXEL's unlevered free cash flow of 27.88M.
2.00%
Worse than EXEL's long-term growth rate of 4.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Worse than EXEL's net debt of -73.05M.
71.33M
Worse than EXEL's equity value of 8.23B.
2.37
Worse than EXEL's equity value per share of 25.62.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
